PVLA
PALVELLA THERAPEUTICS, INC.
Company overview
- Market capitalization
- $2.01B
- Employees
- 29
- Latest publication
- 2026-09-29
About PALVELLA THERAPEUTICS, INC.
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN rapamycin, a novel, 3.9% anhydrous topical gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of angiokeratomas and other mTOR-driven skin diseases; and QTORIN pitavastatin for the treatment of disseminated superficial actinic porokeratosis. The company is based in Wayne, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 9,334,000USD | 7,121,000USD | 6,528,000USD | 5,118,000USD | 4,074,000USD | 2,543,000USD | 3,196,000USD | 1,442,000USD |
| Selling General Administrative | 5,521,000USD | 4,183,000USD | 3,649,000USD | 4,132,000USD | 3,797,000USD | 1,823,000USD | 1,880,000USD | 1,466,000USD |
| Total Operating Expenses | 14,855,000USD | 11,304,000USD | 10,177,000USD | 9,250,000USD | 7,871,000USD | 4,366,000USD | 5,062,000USD | 2,908,000USD |
| Operating Income | -14,855,000USD | -11,304,000USD | -10,177,000USD | -9,250,000USD | -7,871,000USD | -4,366,000USD | -5,062,000USD | -2,908,000USD |
| Interest Income | 1,073,000USD | 520,000USD | 628,000USD | 690,000USD | 752,000USD | — | 187,000USD | — |
| Interest Expense | 2,039,000USD | 1,739,000USD | 1,510,000USD | 1,354,000USD | 1,215,000USD | 1,304,000USD | 1,237,000USD | 1,057,000USD |
| Net Interest Income | -966,000USD | -1,219,000USD | -882,000USD | -664,000USD | -463,000USD | -1,665,000USD | -1,050,000USD | -1,057,000USD |
| Income Before Tax | -15,767,000USD | -12,714,000USD | -11,345,000USD | -9,471,000USD | -8,185,000USD | -3,951,000USD | -6,775,000USD | -4,172,000USD |
| Tax Provision | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income | -15,767,000USD | -12,714,000USD | -11,345,000USD | -9,471,000USD | -8,185,000USD | -3,951,000USD | -6,775,000USD | -4,172,000USD |
| Net Income From Continuing Ops | -15,767,000USD | -12,714,000USD | -11,345,000USD | -9,471,000USD | -8,185,000USD | -3,951,000USD | -6,775,000USD | -4,172,000USD |
| Ebitda | -14,855,000USD | -10,975,000USD | 342,000USD | -8,117,000USD | -6,970,000USD | -4,366,000USD | -2,887,000USD | -3,115,000USD |
| Total Other Income Expense Net | -912,000USD | -1,410,000USD | -1,168,000USD | -221,000USD | -314,000USD | 415,000USD | -1,713,000USD | -1,264,000USD |
| Ebit | — | — | -9,835,000USD | -9,250,000USD | -7,871,000USD | — | -3,135,000USD | -4,176,999USD |
| Depreciation And Amortization | — | — | 10,177,000USD | — | — | — | 5,062,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 25,902,000USD | 31,418,000USD | 29,323,000USD | 46,279,000USD | 29,101,000USD |
| Research Development | 22,841,000USD | 8,151,000USD | 8,793,000USD | 50,212,000USD | 64,197,000USD | 44,220,000USD | 54,364,000USD | 40,920,000USD |
| Selling General Administrative | 15,761,000USD | 5,944,000USD | 3,076,000USD | 4,156,000USD | — | — | — | — |
| Total Operating Expenses | 38,602,000USD | 14,095,000USD | 11,869,000USD | 66,596,000USD | 80,881,000USD | 61,117,000USD | 72,396,000USD | 59,362,000USD |
| Operating Income | -38,602,000USD | -14,095,000USD | -11,869,000USD | -43,474,000USD | -51,831,000USD | -33,921,000USD | -27,157,000USD | -30,831,000USD |
| Interest Income | 2,590,000USD | 642,000USD | 6,265,000USD | — | — | — | — | — |
| Interest Expense | 5,818,000USD | 4,317,000USD | 0USD | — | — | — | — | — |
| Net Interest Income | -3,228,000USD | -4,317,000USD | 6,265,000USD | -10,364,000USD | — | — | — | — |
| Income Before Tax | -41,715,000USD | -17,434,000USD | 18,691,000USD | -33,277,000USD | -45,738,000USD | -37,066,000USD | -25,469,000USD | -27,066,000USD |
| Tax Provision | 0USD | 0USD | 0USD | -1,026,000USD | — | — | — | — |
| Net Income | -41,715,000USD | -17,434,000USD | 18,691,000USD | -33,277,000USD | -45,738,000USD | -37,230,000USD | -25,469,000USD | -26,754,000USD |
| Net Income From Continuing Ops | -41,715,000USD | -17,434,000USD | 18,691,000USD | -27,552,000USD | — | — | — | — |
| Ebitda | -35,897,000USD | -13,117,000USD | 18,691,000USD | -30,497,000USD | -43,370,000USD | -34,939,000USD | -24,429,000USD | -26,496,000USD |
| Total Other Income Expense Net | -3,113,000USD | -3,339,000USD | 30,560,000USD | 10,197,000USD | 6,093,000USD | -3,145,000USD | 1,688,000USD | 3,765,000USD |
| Ebit | — | -14,095,000USD | -11,869,000USD | -33,277,000USD | -45,738,000USD | -37,066,000USD | -25,469,000USD | -27,066,000USD |
| Cost Of Revenue | — | — | — | 2,780,000USD | 2,368,000USD | — | — | — |
| Gross Profit | — | — | — | 23,122,000USD | 29,050,000USD | 29,323,000USD | — | — |
| Selling And Marketing Expenses | — | — | — | 12,228,000USD | — | — | — | — |
| Income Tax Expense | — | — | — | -1,026,000USD | — | 164,000USD | — | -312,000USD |
| Depreciation And Amortization | — | — | — | 2,780,000USD | 2,368,000USD | 2,127,000USD | 1,040,000USD | 570,000USD |
| Unclassified Operating Expenses | — | — | — | — | 16,684,000USD | 16,897,000USD | 18,032,000USD | 18,442,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 253,510,000USD | 263,759,000USD | 59,559,000USD | 66,937,000USD | 73,747,000USD | 79,439,000USD | 88,234,000USD | 20,522,000USD |
| Cash And Equivalents | 187,803,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 250,584,000USD | 261,853,000USD | 57,982,000USD | 63,567,000USD | 70,433,000USD | 75,626,000USD | 83,602,000USD | 19,363,000USD |
| Short Term Investments | 62,781,000USD | 55,459,000USD | — | — | — | — | — | — |
| Total Current Assets | 253,028,000USD | 263,231,000USD | 58,987,000USD | 66,937,000USD | 73,747,000USD | 79,439,000USD | 88,234,000USD | 20,522,000USD |
| Other Current Assets | 2,444,000USD | 1,378,000USD | 1,005,000USD | 1,154,000USD | 1,336,000USD | 1,835,000USD | 2,296,000USD | 280,000USD |
| Total Liabilities | 36,643,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 11,947,000USD | 9,115,000USD | 11,344,000USD | 10,312,000USD | 9,616,000USD | 8,983,000USD | 12,038,000USD | 4,254,000USD |
| Total Stockholder Equity | 216,867,000USD | 232,313,000USD | 27,983,000USD | 38,682,000USD | 47,780,000USD | 55,577,000USD | 62,607,000USD | 16,268,000USD |
| Total Equity Including Noncontrolling Interest | 216,867,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 482,000USD | 528,000USD | 572,000USD | — | — | — | 0USD | — |
| Accounts Payable | 6,785,000USD | 5,443,000USD | 4,595,000USD | 3,481,000USD | 4,557,000USD | 4,441,000USD | 4,586,000USD | 801,000USD |
| Short Term Debt | 217,000USD | 209,000USD | 202,000USD | — | — | — | — | — |
| Common Stock | 14,000USD | 14,000USD | 12,000USD | 11,000USD | 11,000USD | 11,000USD | 11,000USD | 1,000USD |
| Retained Earnings | -173,087,000USD | -151,217,000USD | -135,450,000USD | -122,736,000USD | -111,391,000USD | -101,920,000USD | -93,735,000USD | -326,333,000USD |
| Accumulated Other Comprehensive Income | 89,000USD | 95,000USD | 83,000USD | 104,000USD | -111,000USD | -3,000USD | 3,000USD | -316,000USD |
| Total Liab | — | 31,446,000USD | 31,576,000USD | 28,255,000USD | 25,967,000USD | 23,862,000USD | 25,627,000USD | 4,254,000USD |
| Other Current Liab | — | 3,463,000USD | 6,547,000USD | 6,831,000USD | 5,059,000USD | 4,542,000USD | 7,452,000USD | 3,453,000USD |
| Capital Stock | — | 14,000USD | 12,000USD | 11,000USD | 11,000USD | 11,000USD | 11,000USD | — |
| Cash | — | 206,394,000USD | 57,982,000USD | 63,567,000USD | 70,433,000USD | 75,626,000USD | 83,602,000USD | 19,363,000USD |
| Net Debt | — | -205,810,000USD | -57,349,000USD | -47,546,000USD | -55,922,000USD | -75,626,000USD | -83,602,000USD | -19,363,000USD |
| Short Long Term Debt Total | — | 584,000USD | 633,000USD | 16,021,000USD | 14,511,000USD | — | — | — |
| Property Plant Equipment Gross | — | 528,000USD | 572,000USD | — | — | — | 0USD | — |
| Common Stock Shares Outstanding | — | 13,085,271shares | 11,251,250shares | 11,064,282shares | 11,052,741shares | 2,226,000shares | 2,225,934shares | 1,320,000shares |
| Non Current Assets Total | — | 528,000USD | 572,000USD | 0USD | 0USD | 0USD | 0USD | — |
| Non Current Liabilities Total | — | 22,331,000USD | 20,232,000USD | 17,943,000USD | 16,351,000USD | 14,879,000USD | 13,589,000USD | — |
| Non Current Liabilities Other | — | 19,799,000USD | 17,760,000USD | 16,021,000USD | 14,511,000USD | 13,157,000USD | 11,942,000USD | — |
| Net Working Capital | — | 254,116,000USD | 47,643,000USD | 56,625,000USD | 64,131,000USD | 70,456,000USD | 76,196,000USD | — |
| Unclassified Non Current Liabilities | — | 2,532,000USD | 2,472,000USD | 1,922,000USD | 1,840,000USD | 1,722,000USD | 1,647,000USD | — |
| Unclassified Equity | — | 383,407,000USD | 163,326,000USD | 161,292,000USD | 159,260,000USD | 157,478,000USD | 156,317,000USD | 342,916,000USD |
| Net Receivables | — | — | 0USD | 2,216,000USD | 1,978,000USD | 1,978,000USD | 2,336,000USD | 879,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 59,559,000USD | 88,234,000USD | 7,548,000USD | 16,524,000USD | 153,560,000USD | 105,010,000USD | — | — |
| Other Current Assets | 1,005,000USD | 2,296,000USD | 198,000USD | 471,000USD | 6,548,000USD | 3,579,000USD | — | — |
| Total Liab | 31,576,000USD | 25,627,000USD | 11,428,000USD | 39,698,000USD | 102,805,000USD | 73,983,000USD | — | — |
| Total Stockholder Equity | 27,983,000USD | 62,607,000USD | -3,880,000USD | -23,174,000USD | 50,755,000USD | 31,027,000USD | — | — |
| Other Current Liab | 6,547,000USD | 7,452,000USD | 1,424,000USD | 2,601,000USD | 15,787,000USD | 6,701,000USD | — | — |
| Common Stock | 12,000USD | 11,000USD | — | 74,000USD | 72,000USD | 56,000USD | — | — |
| Capital Stock | 12,000USD | 11,000USD | 70,603,000USD | 70,603,000USD | — | — | — | — |
| Retained Earnings | -135,450,000USD | -93,735,000USD | -76,301,000USD | -94,992,000USD | -257,144,000USD | -211,406,000USD | — | — |
| Cash | 57,982,000USD | 83,602,000USD | 7,350,000USD | 16,053,000USD | 117,764,000USD | 70,436,000USD | — | — |
| Cash And Short Term Investments | 57,982,000USD | 83,602,000USD | 7,350,000USD | 16,053,000USD | 117,764,000USD | 70,436,000USD | — | — |
| Total Current Assets | 58,987,000USD | 88,234,000USD | 7,548,000USD | 16,524,000USD | 127,625,000USD | 75,721,000USD | — | — |
| Total Current Liabilities | 11,344,000USD | 12,038,000USD | 2,360,000USD | 5,782,000USD | 50,561,000USD | 22,145,000USD | — | — |
| Net Debt | -57,349,000USD | -83,602,000USD | -7,350,000USD | -16,053,000USD | -102,874,000USD | -53,474,000USD | — | — |
| Short Term Debt | 202,000USD | — | — | 859,000USD | 1,049,000USD | 1,030,000USD | — | — |
| Short Long Term Debt Total | 633,000USD | 11,942,000USD | 78,657,000USD | 13,103,000USD | 14,890,000USD | 16,962,000USD | — | — |
| Net Receivables | 0USD | 2,336,000USD | 0USD | 5,810,000USD | 3,313,000USD | 1,706,000USD | — | — |
| Accounts Payable | 4,595,000USD | 4,586,000USD | 936,000USD | 3,181,000USD | 8,609,000USD | 1,787,000USD | — | — |
| Property Plant Equipment Net | 572,000USD | 0USD | — | — | 23,031,000USD | 25,980,000USD | — | — |
| Property Plant Equipment Gross | 572,000USD | 0USD | — | — | — | — | — | — |
| Accumulated Other Comprehensive Income | 83,000USD | 3,000USD | 28,000USD | -254,000USD | 829,000USD | -295,000USD | — | — |
| Common Stock Shares Outstanding | 11,251,250shares | 2,226,000shares | 1,268,000shares | 930,352shares | 806,837shares | 681,012shares | 632,812shares | 663,512shares |
| Non Current Assets Total | 572,000USD | 0USD | 0USD | 22,065,999USD | 25,935,000USD | 29,289,000USD | — | — |
| Non Current Liabilities Total | 20,232,000USD | 13,589,000USD | 9,068,000USD | 33,916,000USD | 52,244,000USD | 51,838,000USD | — | — |
| Non Current Liabilities Other | 17,760,000USD | 11,942,000USD | 8,054,000USD | 32,417,000USD | — | — | — | — |
| Net Working Capital | 47,643,000USD | 76,196,000USD | 5,188,000USD | 10,742,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | 2,472,000USD | 1,647,000USD | 1,014,000USD | 1,499,000USD | 52,244,000USD | 51,838,000USD | — | — |
| Unclassified Equity | 163,326,000USD | 156,317,000USD | 1,790,000USD | 1,395,000USD | 306,998,000USD | 242,672,000USD | — | — |
| Short Term Investments | — | — | — | 20,534,000USD | — | — | — | — |
| Non Currrent Assets Other | — | — | — | 22,065,999USD | 2,904,000USD | 3,309,000USD | — | — |
| Unclassified Current Assets | — | — | — | -26,344,000USD | — | — | — | — |
| Current Deferred Revenue | — | — | — | — | 25,116,000USD | 12,627,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -15,767,000USD | -7,065,000USD | -11,345,000USD | -9,471,000USD | -8,185,000USD | -3,951,000USD | -6,775,000USD | -4,171,999USD |
| Stock Based Compensation | 3,376,000USD | 1,136,000USD | 1,790,000USD | 1,433,000USD | 1,094,000USD | 268,000USD | 199,000USD | 217,000USD |
| Other Non Cash Items | 5,309,000USD | -2,801,000USD | 3,620,000USD | 1,472,000USD | 1,290,000USD | 1,886,000USD | 1,825,000USD | 1,351,000USD |
| Change In Working Capital | -406,000USD | 3,804,000USD | -153,000USD | 1,132,000USD | -967,000USD | -3,596,000USD | 1,934,000USD | 1,000,999USD |
| Total Cash From Operating Activities | -10,864,000USD | -4,926,000USD | -7,878,000USD | -5,434,000USD | -6,768,000USD | -5,393,000USD | -2,742,000USD | -1,603,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | -13,000USD | 0USD | 0USD |
| Free Cash Flow | -10,864,000USD | -4,926,000USD | -7,878,000USD | -5,434,000USD | -6,768,000USD | -5,393,000USD | -2,742,000USD | -1,603,000USD |
| Investments | -55,440,000USD | — | — | — | 0USD | — | — | — |
| Total Cashflows From Investing Activities | -55,440,000USD | — | — | — | — | -3,449,000USD | — | — |
| Total Cash From Financing Activities | 214,731,000USD | -49,000USD | 242,000USD | 349,000USD | -1,202,000USD | 74,785,000USD | 2,412,000USD | 9,892,000USD |
| Issuance Of Capital Stock | 230,000,000USD | — | — | — | 0USD | — | — | — |
| Change In Cash | 148,412,000USD | -5,585,000USD | -6,866,000USD | -5,193,000USD | 56,263,000USD | 69,395,000USD | -330,000USD | 647,000USD |
| Begin Period Cash Flow | 57,982,000USD | 63,567,000USD | 70,433,000USD | 75,626,000USD | 19,363,000USD | 14,207,000USD | 14,537,000USD | 19,084,000USD |
| End Period Cash Flow | 206,394,000USD | 57,982,000USD | 63,567,000USD | 70,433,000USD | 75,626,000USD | 83,602,000USD | 14,207,000USD | 19,731,000USD |
| Other Cashflows From Financing Activities | -16,225,000USD | -154,000USD | 242,000USD | 349,000USD | -1,269,000USD | 68,785,000USD | — | — |
| Unclassified Operating Cash Flow | -3,376,000USD | — | -1,790,000USD | — | — | — | — | — |
| Change To Account Receivables | — | 2,134,000USD | 0USD | 358,000USD | 358,000USD | — | 0USD | 0USD |
| Net Borrowings | — | 0USD | 0USD | — | — | 66,001,000USD | 2,433,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | -3,436,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | -60,001,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -41,715,000USD | -17,434,000USD | 18,691,000USD | -27,552,000USD | -45,738,000USD | -37,230,000USD |
| Stock Based Compensation | 6,401,000USD | 830,000USD | 603,000USD | 427,000USD | — | — |
| Other Non Cash Items | 6,492,000USD | 5,957,000USD | -29,848,000USD | 10,664,000USD | 5,185,000USD | 5,419,999USD |
| Change To Account Receivables | 2,492,000USD | -1,978,000USD | — | -2,624,000USD | -1,813,000USD | 5,343,000USD |
| Change In Working Capital | 3,816,000USD | -193,000USD | -3,149,000USD | 1,621,000USD | 30,525,000USD | -16,376,999USD |
| Total Cash From Operating Activities | -25,006,000USD | -10,840,000USD | -13,703,000USD | -14,840,000USD | -7,660,000USD | -45,896,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -1,041,000USD | -949,000USD | -2,726,000USD |
| Free Cash Flow | -25,006,000USD | -10,840,000USD | -13,703,000USD | -14,840,000USD | -8,609,000USD | -48,622,000USD |
| Net Borrowings | 0USD | 78,434,000USD | 0USD | — | — | — |
| Total Cash From Financing Activities | -660,000USD | 87,089,000USD | 5,000,000USD | 9,566,000USD | 59,127,000USD | 10,115,000USD |
| Change In Cash | -25,620,000USD | 76,252,000USD | -8,703,000USD | -5,274,000USD | 47,328,000USD | 8,176,000USD |
| Begin Period Cash Flow | 83,602,000USD | 7,350,000USD | 16,053,000USD | 21,327,000USD | 70,436,000USD | 62,260,000USD |
| End Period Cash Flow | 57,982,000USD | 83,602,000USD | 7,350,000USD | 16,053,000USD | 117,764,000USD | 70,436,000USD |
| Other Cashflows From Financing Activities | -1,423,000USD | 8,655,000USD | 5,000,000USD | 9,566,000USD | — | — |
| Issuance Of Capital Stock | — | — | 0USD | 9,532,000USD | — | — |
| Total Cashflows From Investing Activities | — | — | — | -21,236,000USD | -949,000USD | 39,212,000USD |
| Unclassified Investing Cash Flow | — | — | — | -20,195,000USD | — | 41,938,000USD |
| Unclassified Financing Cash Flow | — | — | — | -9,532,000USD | — | — |
| Depreciation | — | — | — | — | 2,368,000USD | 2,127,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q3 2020Quarterly · 2020-09-30 | Product | Collaboration Revenue | 361,000 | USD | 0001583648-20-000061 |
| Q3 2020Quarterly · 2020-09-30 | Product | Customer Revenue | 2,578,000 | USD | 0001583648-20-000061 |
| Q2 2020Quarterly · 2020-06-30 | Product | Collaboration Revenue | 316,000 | USD | 0001583648-20-000046 |
| Q2 2020Quarterly · 2020-06-30 | Product | Customer Revenue | 10,930,000 | USD | 0001583648-20-000046 |
| Q1 2020Quarterly · 2020-03-31 | Product | Collaboration Revenue | 4,376,000 | USD | 0001583648-20-000026 |
| Q1 2020Quarterly · 2020-03-31 | Product | Customer Revenue | 8,885,000 | USD | 0001583648-20-000026 |
| Q4 2019Quarterly · 2019-12-31 | Product | Collaboration Revenue | 743,000 | USD | Legacy provider |
| Q4 2019Quarterly · 2019-12-31 | Product | Customer Revenue | 16,527,000 | USD | Legacy provider |
| FY 2019Yearly · 2019-12-31 | Product | Collaboration Revenue | 14,214,000 | USD | 0001583648-21-000005 |
| FY 2019Yearly · 2019-12-31 | Product | Customer Revenue | 32,065,000 | USD | 0001583648-21-000005 |
| Q3 2019Quarterly · 2019-09-30 | Product | Collaboration Revenue | 11,543,000 | USD | 0001583648-20-000061 |
| Q3 2019Quarterly · 2019-09-30 | Product | Customer Revenue | 3,589,000 | USD | 0001583648-20-000061 |
| Q2 2019Quarterly · 2019-06-30 | Product | Collaboration Revenue | 609,000 | USD | 0001583648-20-000046 |
| Q2 2019Quarterly · 2019-06-30 | Product | Customer Revenue | 4,723,000 | USD | 0001583648-20-000046 |
| Q1 2019Quarterly · 2019-03-31 | Product | Collaboration Revenue | 1,319,000 | USD | 0001583648-20-000026 |
| Q1 2019Quarterly · 2019-03-31 | Product | Customer Revenue | 7,226,000 | USD | 0001583648-20-000026 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.